(Q45949161)

18 December 2017

title

Cetuximab, chemotherapy and KRAS status in mCRC. (English)

1 reference

18 December 2017

1 reference

1 reference

Sharlene Gill

1

1 reference

18 December 2017

Richard M Goldberg

series ordinal

2

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 July 2009

1 reference

18 December 2017

Nature Reviews Clinical Oncology

published in

1 reference

18 December 2017

volume

6

1 reference

18 December 2017

issue

7

1 reference

18 December 2017

page(s)

379-380

1 reference

18 December 2017

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.83

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.83

Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.83

Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.83

Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.83

KRAS mutations and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: practical application of patient selection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.83

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.83

Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.83

A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.83

10.1038/NRCLINONC.2009.83

31 March 2020

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017